AnalystsLaura Prendergast
Laura Prendergast's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 16%
#816 out of 5208 analysts
Average Return
+62.2%
Win Rate
39%7 out of 18
Risk vs Reward
Poor
Good

Laura Prendergast's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Erasca IncERAS
+852.70%$1.48$14.10
2025-03-25 -
2026-03-03
Buy
Erasca IncERAS
+457.31%$2.53$14.10
2025-10-15 -
2026-03-03
Strong Buy
Revolution Medicines IncRVMD
+102.27%$49.68$100.49
2025-10-15 -
2026-03-03
Strong Buy
Revolution Medicines IncRVMD
+45.95%$27.38$39.96
2024-01-15 -
2025-01-15
Buy
Foghorn Therapeutics IncFHTX
+20.52%$4.58$5.52
2025-12-03 -
2026-03-03
Strong Buy

Laura Prendergast Analyst Color

Get additional color on Laura Prendergast's coverage of popular stocks

Laura Prendergast's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Olema Pharmaceuticals IncOLMA
1Strong Buy$48.00+104.87%Initiates Coverage On
21 days ago
Bridgebio Oncology Therapeutics IncBBOT
1Strong Buy$23.00+136.14%Initiates Coverage On
21 days ago
Revolution Medicines IncRVMD
4Strong Buy$170.00+69.17%Maintains
a month ago
Tango Therapeutics IncTNGX
1Strong Buy$15.00+30.43%Initiates Coverage On
3 months ago
Foghorn Therapeutics IncFHTX
1Strong Buy$12.00+117.39%Initiates Coverage On
3 months ago
Nuvalent IncNUVL
2Strong Buy$135.00+34.70%Maintains
4 months ago
Black Diamond Therapeutics IncBDTX
2Strong Buy$8.00+247.83%Reinstates
5 months ago
Erasca IncERAS
2Strong Buy$4.00-71.63%Initiates Coverage On
5 months ago
Cogent Biosciences IncCOGT
1Hold$16.00-57.04%Initiates Coverage On
5 months ago
Mural Oncology PLCMURA
1Strong Buy$18.00N/AInitiates Coverage On
a year ago
Nkarta IncNKTX
2Strong Buy$16.00N/AUpgrades
2 years ago
Third Harmonic Bio IncTHRD
1Buy$18.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.